Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Curis doses first patient in phase I CUDC-101 trial

Aug. 27, 2008

AVEO initiates phase Ib combination trial of AV-951 and FOLFOX-6

Aug. 27, 2008

Pfizer unveils potent and selective c-Met inhibitor PF-4254644

Aug. 27, 2008

MMRC and Celgene collaborate on phase I/II pomalidomide trial

Aug. 26, 2008

FDA grants fast track designation for OncoGenex's anticancer agent OGX-011

Aug. 25, 2008

Chemokine receives Hong Kong approval to initiate phase II CTCE-9908 trial

Aug. 25, 2008

Delcath expands phase III percutaneous hepatic perfusion trial in melanoma

Aug. 25, 2008

Everolimus improves progression-free survival in metastatic renal cell carcinoma patients

Aug. 25, 2008

Phase III trial commences for Nexavar as adjuvant therapy in liver cancer

Aug. 22, 2008

Vidaza receives expanded FDA approval in high-risk MDS patients

Aug. 22, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...